PRIMARY HIV INFECTION PROTOCOLS
Past & Present Performance: HIV/AIDS Multicenter Clinical Trials (3/87 - 4/98)
conducted by the Tulane-LSU AIDS Clinical Trials Collaborative Programs


Phase I
Pharmacokinetc
n=
Phase II
n=
Phase II/III
n=
Phase III
n=
Women's 
Health
n=
Pediatric/
Adolescent
n=
DATRI 001
3
 ACTG 047
8
 ACTG 001
1
 ACTG 002
16
 ACTG 875
7
 ACTG 051
1
ACTG 022
1
 ACTG 140
1
 ACG 063
4
 ACTG 016
22
 ACTG 200
1
 ACTG 076
30
ACTG 35
13
 ACTG 248
4
 ACTG 068
10
 ACTG 019
98
 ACTG 128
1
ACTG 050
8
 ACTG 313
11
 ACTG 112
1
 ACTG 020
49
 ACTG 138
3
ACTG 066E
1
 ACTG 328
12
 ACTG 116
35
 ACTG 036
9
 ACTG 139
1
ACTG 191
6
 ACTG 343
11
 ACTG 117
10
 ACTG 155
16
 ACTG 152
4
ACTG 201
12
 ACTG 368
6
 ACTG 118
5
 VX-93-3
26
 ACTG 220
8
NV 15107
8
 ACTG 372
6
 ACTG 175
58
 VX-94-6
22
ACTG 329
5
 ACTG 359
5
 CYST 9304
6
 GCSF 930101
6
ACTG 333
6
 NV 14256
23
 M/3331/0017
10
NV 15355
2
 M/3331/0021
4
GS-96-408
8
 SV 14604
26
ACTG 336
2
 SV 14788
5
ACTG 242
1
 M94-247
15
M-033
16
M96-432
5
M/3331/0023
3
DMP 266-20
4
ACTG 320
21
ACTG 293
13
CNAA/B3005
7
PROA/B3006
0
Total Enrolled
57
70
166
393
8
48